Publications of Jonathan S Serody - ReachNC

76 Publications

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

sort by year | cited by

Select All | Save icon

Export

1.
2013

W A Wood; A M Deal; B B Reeve; A P Abernethy; E Basch; S A Mitchell; C Shatten; Y Hie Kim; J Whitley; J S Serody; et al.

Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study
Bone Marrow Transplantation. 2013.

0
2.
2013

William A. Wood; Allison M. Deal; Amy Abernethy; Ethan Basch; Claudio Battaglini; Yoon Hie Kim; Julia Whitley; Charlotte Shatten; Jon Serody; Thomas Shea; et al.

Feasibility of Frequent Patient-Reported Outcome Surveillance in Patients Undergoing Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation. 2013;19(3):450-459.

0
3.
2012

W A Wood; J Whitley; R Goyal; P M Brown; A Sharf; R Irons; K V Rao; A Essenmacher; J S Serody; J M Coghill; et al.

Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT
Bone Marrow Transplantation. 2012.

0
4.
2012

Jessica L. Allen; Matthew S. Fore; Jenna Wooten; Philip A. Roehrs; Nazmim S. Bhuiya; Todd Hoffert; Andrew Sharf; Allison M. Deal; Paul Armistead; James Coghill; et al.

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways
Blood. 2012;120(12):2529-2536.

1
5.
2012

LeShara M. Fulton; Michael J. Carlson; James M. Coghill; Laura E. Ott; Michelle L. West; Angela Panoskaltsis-Mortari; Dan R. Littman; Bruce R. Blazar; Jonathan S. Serody

Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt
Journal of Immunology. 2012;189(4):1765-1772.

0
6.
2012

Jonathan Serody

Bacterial sepsis and GI tract GVHD: More commensal than you think
Blood. 2012;120(1):6-7.

0
7.
2012

Yuri Fedoriw; T. Danielle Samulski; Allison M. Deal; Cherie H. Dunphy; Andrew Sharf; Thomas C. Shea; Jonathan S. Serody; Stefanie Sarantopoulos

Bone Marrow B cell Precursor Number after Allogeneic Stem Cell Transplantation and GVHD Development
Biology of Blood and Marrow Transplantation. 2012;18(6):968-973.

1
8.
2012

Jonathan S. Serody; Geoffrey R. Hill

The IL-17 Differentiation Pathway and Its Role in Transplant Outcome
Biology of Blood and Marrow Transplantation. 2012;18(1 SUPPL.):S56-S61.

5
9.
2011

William Wood; Allison Deal; Julia Whitley; Andrew Sharf; Jonathan Serody; Donald Gabriel; Thomas Shea

Usefulness of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in predicting outcomes for adolescents and young adults with hematologic malignancies undergoing allogeneic stem cell transplant
Pediatric Blood and Cancer. 2011;57(3):499-505.

1
10.
2011

James M. Coghill; Stefanie Sarantopoulos; Timothy P. Moran; William J. Murphy; Bruce R. Blazar; Jonathan S. Serody

Effector CD4 ⁺ T cells, the cytokines they generate, and GVHD: Something old and something new
Blood. 2011;117(12):3268-3276.

17
11.
2011

Anne W. Beaven; Dominic T. Moore; Andrew Sharf; Jonathan S. Serody; Thomas C. Shea; Don A. Gabriel

Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma
Cancer Investigation. 2011;29(3):214-219.

0
12.
2011

William A. Wood; Julia Whitley; Dominic Moore; Andrew Sharf; Robert Irons; Kamakshi Rao; Jonathan Serody; Jay Coghill; Donald Gabriel; Thomas Shea

Chemomobilization with etoposide is highly effective in patients with multiple myeloma and overcomes the effects of age and prior therapy
Biology of Blood and Marrow Transplantation. 2011;17(1):141-146.

2
13.
2010

Steven L. Highfill; Paulo C. Rodriguez; Qing Zhou; Christine A. Goetz; Brent H. Koehn; Rachelle Veenstra; Patricia A. Taylor; Angela Panoskaltsis-Mortari; Jonathan S. Serody; David H. Munn; et al.

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13
Blood. 2010;116(25):5738-5747.

44
14.
2010

Hendrik W. Van Deventer; Joseph E. Burgents; Qing Ping Wu; Rita-Marie T. Woodford; W. June Brickey; Irving C. Allen; Erin McElvania-Tekippe; Jonathan S. Serody; Jenny P.-Y. Ting

The inflammasome component Nlrp3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells
Cancer Research. 2010;70(24):10161-10169.

11
15.
2010

M.J. Carlson; L.M. Fulton; J.M. Coghill; M.L. West; J.E. Burgents; Y. Wan; A. Panoskaltsis-Mortari; T.F. Tedder; B.R. Blazar; J.S. Serody

L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation
American Journal of Transplantation. 2010;10(12):2596-2603.

2
16.
2010

James M. Coghill; Michael J. Carlson; Angela Panoskaltsis-Mortari; Michelle L. West; Joseph E. Burgents; Bruce R. Blazar; Jonathan S. Serody

Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells
Blood. 2010;115(23):4914-4922.

11
17.
2010

Joseph E. Burgents; Timothy P. Moran; Michelle L. West; Nancy L. Davis; Robert E. Johnston; Jonathan S. Serody

The immunosuppressive tumor environment is the major impediment to successful therapeutic vaccination in neu transgenic mice
Journal of Immunotherapy. 2010;33(5):482-491.

4
18.
2010

William Wood; Seema Garg; Grazyna Adamus; Donald Gabriel; Thomas Shea; Jonathan Serody

Alloimmune Retinopathy Associated with Antibodies to Transducin-α as a Complication of Chronic Graft-Versus-Host Disease
Biology of Blood and Marrow Transplantation. 2010;16(1):135-138.

0
19.
2009

M.J. O'Shaughnessy; C. Vogtenhuber; K. Sun; R. Sitcheran; A.S. Baldwin; W.J. Murphy; L. Dang; B. Jaffee; E. Palmer; J.S. Serody; et al.

Ex vivo inhibition of NF-κB signaling in alloreactive T-cells prevents graft-versus-host disease
American Journal of Transplantation. 2009;9(3):452-462.

6
20.
2009

Kamakshi V. Rao; Larry W. Buie; Thomas Shea; Don A. Gabriel; Terrance Comeau; Robert Irons; Jonathan Serody; Barbara Eron

Intravesicular Cidofovir for the Management of BK Virus-Associated Cystitis
Biology of Blood and Marrow Transplantation. 2009;15(3):391-392.

6
21.
2009

Michael J. Carlson; Michelle L. West; James M. Coghill; Angela Panoskaltsis-Mortari; Bruce R. Blazar; Jonathan S. Serody

In vitro differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
Blood. 2009;113(6):1365-1374.

93
22.
2009

Thomas C. Shea; Anne W. Beaven; Dominic Moore; Jonathan Serody; Don Gabriel; Nelson Chao; Jon Gockerman; Reynaldo A. Garcia; David Rizzieri

Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: Increased toxicity without improvement in progression-free survival
Leukemia and Lymphoma. 2009;50(5):741-748.

2
23.
2008

Amanda Peppercorn; Jonathan Serody; Bruce Cairns

Reactivation of cytomegalovirus infection in critically ill immunocompetent patients
JAMA - Journal of the American Medical Association. 2008;300(20):2367-2368.

2
24.
2008

Patricia A. Taylor; Michael J. Ehrhardt; Christopher J. Lees; Angela Panoskaltsis-Mortari; Arthur M. Krieg; Arlene H. Sharpe; William J. Murphy; Jonathan S. Serody; Hiroaki Hemmi; Shizuo Akira; et al.

TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection
Blood. 2008;112(8):3508-3516.

30
25.
2008

Hendrik W. Van Deventer; Ping Wu Qing; Daniel T. Bergstralh; Beckley K. Davis; Brian P. O'Connor; Jenny P.-Y. Ting; Jonathan S. Serody

C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9
American Journal of Pathology. 2008;173(1):253-264.

31
26.
2008

James M. Coghill; Michael J. Carlson; Tim P. Moran; Jonathan S. Serody

The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting
Leukemia and Lymphoma. 2008;49(10):1860-1869.

12
27.
2007

Kimberly B. Petermann; Gabriela I. Rozenberg; Daniel Zedek; Pamela Groben; Karen McKinnon; Christin Buehler; William Y. Kim; Janiel M. Shields; Shannon Penland; James E. Bear; et al.

CD200 is induced by ERK and is a potential therapeutic target in melanoma
Journal of Clinical Investigation. 2007;117(12):3922-3929.

37
28.
2007

Patricia A. Taylor; Michael J. Ehrhardt; Christopher J. Lees; Jakub Tolar; Brenda J. Weigel; Angela Panoskaltsis-Mortari; Jonathan S. Serody; Volker Brinkmann; Bruce R. Blazar

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)
Blood. 2007;110(9):3480-3488.

23
29.
2007

Timothy P. Moran; Joseph E. Burgents; Brian Long; Ivana Ferrer; Elizabeth M. Jaffee; Roland M. Tisch; Robert E. Johnston; Jonathan S. Serody

Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice
Vaccine. 2007;25(36):6604-6612.

13
30.
2007

Patricia A. Taylor; Michael J. Ehrhardt; Matthew M. Roforth; Jessica M. Swedin; Angela Panoskaltsis-Mortari; Jonathan S. Serody; Bruce R. Blazar

Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients
Blood. 2007;109(3):1307-1315.

42
31.
2006

Jonathan Serody

The CCCR deletion mutation and graft-versus-host disease
Haematologica. 2006;91(12):1586.

1
32.
2006

Andrew L. Gilman; Jonathan Serody

Diagnosis and treatment of chronic graft-versus-host disease
Seminars in Hematology. 2006;43(1):70-80.

17
33.
2006

Jonathan S. Serody; Tim Moran

Role for CCR5 in the function of regulatory T cells
Modern Aspects of Immunobiology. 2006;18:40.

0
34.
2005

Don A. Gabriel; Thomas C. Shea; Jonathan S. Serody; Dominic T. Moore; Suzanne L. Kirby; Donald Harvey; Carol Krasnov

Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies
Biology of Blood and Marrow Transplantation. 2005;11(12):1022-1030.

11
35.
2005

Christian A. Wysocki; Qi Jiang; Angela Panoskaltsis-Mortari; Patricia A. Taylor; Karen P. McKinnon; Lishan Su; Bruce R. Blazar; Jonathan S. Serody

Critical role for CCR5 in the function of donor CD4⁺CD25 ⁺ regulatory T cells during acute graft-versus-host disease
Blood. 2005;106(9):3300-3307.

128
36.
2005

Timothy P. Moran; Martha Collier; Karen P. McKinnon; Nancy L. Davis; Robert E. Johnston; Jonathan S. Serody

A novel viral system for generating antigen-specific T cells
Journal of Immunology. 2005;175(5):3431-3438.

32
37.
2005

Christian A. Wysocki; Angela Panoskaltsis-Mortari; Bruce R. Blazar; Jonathan S. Serody

Leukocyte migration and graft-versus-host disease
Blood. 2005;105(11):4191-4199.

127
38.
2005

Patricia A. Taylor; Angela Panoskaltsis-Mortari; Gordon J. Freeman; Arlene H. Sharpe; Randolph J. Noelle; Alexander Y. Rudensky; Tak W. Mak; Jonathan S. Serody; Bruce R. Blazar

Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM)
Blood. 2005;105(8):3372-3380.

44
39.
2005

Hendrik W. Van Deventer; William O'Connor Jr.; W. June Brickey; Robert M. Aris; Jenny P.Y. Ting; Jonathan S. Serody

C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis
Cancer Research. 2005;65(8):3374-3379.

22
40.
2005

Gerhard C. Hildebrandt; Krystyna M. Olkiewicz; Sung Choi; Leigh A. Corrion; Shawn G. Clouthier; Chen Liu; Jonathan S. Serody; Kenneth R. Cooke

Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation
Blood. 2005;105(6):2249-2257.

20
41.
2004

Patricia A. Taylor; Angela Panoskaltsis-Mortari; Jessica M. Swedin; Philip J. Lucas; Ronald E. Gress; Bruce L. Levine; Carl H. June; Jonathan S. Serody; Bruce R. Blazar

L-selectin^hi but not the L-selectin^lo CD4 ⁺25⁺ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection
Blood. 2004;104(12):3804-3812.

191
42.
2004

E. Claire Dees; Karen P. McKinnon; Jennifer J. Kuhns; Kathryn A. Chwastiak; Scotty Sparks; Mary Myers; Edward J. Collins; Jeffrey A. Frelinger; Henrik Van Deventer; Frances Collichio; et al.

Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer
Cancer Immunology, Immunotherapy. 2004;53(9):777-785.

25
43.
2004

Bruce R. Blazar; Robert B. Levy; Tak W. Mak; Angela Panoskaltsis-Mortari; Hiromi Muta; Monica Jones; Melinda Roskos; Jonathan S. Serody; Hideo Yagita; Eckhard R. Podack; et al.

CD30/CD30 ligand (CD153) interaction regulates CD4⁺ T cell-mediated graft-versus-host disease
Journal of Immunology. 2004;173(5):2933-2941.

33
44.
2004

Kai Sun; Lisbeth A. Welniak; Angela Panoskaltsis-Mortari; Matthew J. O'Shaughnessy; Haiyan Liu; Isabel Barao; William Riordan; Raquel Sitcheran; Christian Wysocki; Jonathan S. Serody; et al.

Erratum: Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib (Proceedings of the National Academy of Sciences of the United States of America (May 25, 2004) 101, 21 (8120-8125))
Proceedings of the National Academy of Sciences of the United States of America. 2004;101(34):12777.

1
45.
2004

Christian A. Wysocki; Susan B. Burkett; Angela Panoskaltsis-Mortari; Suzanne L. Kirby; Andrew D. Luster; Karen McKinnon; Bruce R. Blazar; Jonathan S. Serody

Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning
Journal of Immunology. 2004;173(2):845-854.

65
46.
2004

Celeste Lindley; Thomas Shea; Jeannine McCune; Stacy Shord; Jodi Decker; Donald Harvey; William P. Petros; Don Garbriel; Jonathan Serody; Suzanne Kirby; et al.

Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: Assessment of a test dose and first dose strategy
Anti-Cancer Drugs. 2004;15(5):453-459.

16
47.
2004

Martin G. Sauer; Marna E. Ericson; Brenda J. Weigel; Michael J. Herron; Angela Panoskaltsis-Mortari; Betsy T. Kren; Bruce L. Levine; Jon S. Serody; Carl H. June; et al.

A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells
Cancer Research. 2004;64(11):3914-3921.

20
48.
2004

Kai Sun; Lisbeth A. Welniak; Angela Panoskaltsis-Mortari; Matthew J. O'Shaughnessy; Haiyan Liu; Isabel Barao; William Riordan; Raquel Sitcheran; Christian Wysocki; Jonathan S. Serody; et al.

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitior bortezomib
Proceedings of the National Academy of Sciences of the United States of America. 2004;101(21):8120-8125.

134
49.
2004

Angela Panoskaltsis-Mortari; Andrew Price; John R. Hermanson; Elizabeth Taras; Chris Lees; Jonathan S. Serody; Bruce R. Blazar

In vivo imaging of graft-versus-host-disease in mice
Blood. 2004;103(9):3590-3598.

66
50.
2003

Don A. Gabriel; Thomas Shea; Oludamilola Olajida; Jonathan S. Serody; Terrance Comeau

The Effect of Oral Mucositis on Morbidity and Mortality in Bone Marrow Transplant
Seminars in Oncology. 2003;30(6 SUPPL. 18):76-83.

27
51.
2003

Thomas C. Shea; Rebecca Bruner; Joseph M. Wiley; Jonathan S. Serody; Scott Sailer; Don A. Gabriel; Eileen Capel; Dominic T. Moore; Georgette Dent; Stuart Bentley; et al.

An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies
Biology of Blood and Marrow Transplantation. 2003;9(7):443-452.

6
52.
2003

Angela Panoskaltsis-Mortari; John R. Hermanson; Elizabeth Taras; O. Douglas Wangensteen; Jonathan S. Serody; Bruce R. Blazar

Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1α (CCL3) after allogeneic BMT in mice
Blood. 2003;101(9):3714-3721.

25
53.
2003

Judith Ng-Cashin; Jennifer J. Kuhns; Susan E. Burkett; John D. Powderly; Robin R. Craven; Hank W. Van Deventer; Suzanne L. Kirby; Jonathan S. Serody

Host absence of CCR5 potentiates dendritic cell vaccination
Journal of Immunology. 2003;170(8):4201-4208.

15
54.
2002

Hendrik W. Van Deventer; Jonathon S. Serody; Karen P. McKinnon; Casey Clements; W. June Brickey; Jenny P.-Y. Ting

Transfection of macrophage inflammatory protein 1α into B16 F10 melanoma cells inhibits growth of pulmonary metastases but not subcutaneous tumors
Journal of Immunology. 2002;169(3):1634-1639.

31
55.
2001

Thomas C. Shea; Jonathan Serody; Joseph Wiley; Eileen Capel; Donald Gabriel; Sharon Bigelow; Suzanne Kirby

Allogeneic bone marrow transplantation using cytokine stimulated bone marrow
Cancer Research, Therapy and Control. 2001;11(1):27-31.

0
56.
2001

E.C. Dees; K. McKinnon; M. Myers; S.D. Sparks; K. Chwastiak; F. Collichio; H. VanDeventer; L.A. Carey; M.E. Brecher; M. Graham; et al.

Phase I clinical trial of HER2 peptide-pulsed autologous dendritic cells in patients with metastatic breast cancer (MBC)
Breast Cancer Research and Treatment. 2001;69(3):311.

1
57.
2001

Don A. Gabriel; Jonathan S. Serody; Suzanne Kirby; Eileen Capel; Sharon Bigelow; Dominic Moore; Thomas C. Shea

Efficacy of peripheral blood stem cell or mobilized marrow transplant in the treatment of refractory multiple myeloma
Blood. 2001;96(11 PART II):354b.

0
58.
2000

J.S. Serody; S.E. Burkett; A. Panoskaltsis-Mortari; J. Ng-Cashin; E. McMahon; G.K. Matsushima; S.A. Lira; D.N. Cook; B.R. Blazar

T-lymphocyte production of macrophage inflammatory protein-1α is critical to the recruitment of CD8⁺ T cells to the liver, lung, and spleen during graft-versus-host disease
Blood. 2000;96(9):2973-2980.

87
59.
2000

Jonathan S. Serody; Edward J. Collins; Roland M. Tisch; Jennifer J. Kuhns; Jeffrey A. Frelinger

T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery
Journal of Immunology. 2000;164(9):4961-4967.

67
60.
2000

J.S. Serody; P.A. Pizzo

Fever in immunocompromised patients [5] (multiple letters)
New England Journal of Medicine. 2000;342(3):217-218.

10
61.
2000

Jonathan S. Serody; Scotty D. Sparks; Yuhua Lin; Eileen J. Capel; Sharon H. Bigelow; Suzanne L. Kirby; Don A. Gabriel; Joseph M. Wiley; Mark E. Brecher; et al.

Comparison of Granulocyte Colony-Stimulating Factor (G-CSF)-Mobilized Peripheral Blood Progenitor Cells and G-CSF-Stimulated Bone Marrow as a Source of Stem Cells in HLA-Matched Sibling Transplantation
Biology of Blood and Marrow Transplantation. 2000;6(4 A):434-440.

36
62.
2000

J.S. Serody; M.M. Berrey; K. Albritton; S.M. O'brien; E.P. Capel; S.H. Bigelow; D.J. Weber; D.A. Gabriel; J.M. Wiley; M.J. Schell; et al.

Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation
Bone Marrow Transplantation. 2000;26(5):533-538.

18
63.
1999

Donald N. Cook; Oliver Smithies; Robert M. Strieter; Jeffrey A. Frelinger; Jonathan S. Serody

CD8⁺ T cells are a biologically relevant source of macrophage inflammatory protein-1α in vivo
Journal of Immunology. 1999;162(9):5423-5428.

55
64.
1999

Jonathan S. Serody; Donald N. Cook; Suzanne L. Kirby; Elizabeth Reap; Thomas C. Shea; Jeffrey A. Frelinger

Murine T lymphocytes incapable of producing macrophage inhibitory protein-1α are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier
Blood. 1999;93(1):43-50.

32
65.
1998

Jeffrey A. Frelinger; Jonathan Serody

Immune response of β₂-microglobulin-deficient mice to pathogens
Current Topics in Microbiology and Immunology. 1998;232:99-114.

2
66.
1997

S.A. Bentley; M.E. Brecher; E. Powell; J.S. Serody; J.M. Wiley; T.C. Shea

Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: Differences between peripheral blood stem cell and bone marrow recipients
Bone Marrow Transplantation. 1997;19(6):557-563.

19
67.
1997

J.S. Serody; T.C. Shea

Prevention of infections in bone marrow transplant recipients
Infectious Disease Clinics of North America. 1997;11(2):459-477.

23
68.
1997

Jonathan S. Serody; Mark E. Brecher; Georgette Dent; Stuart A. Bentley; Jeffrey A. Frelinger; Thomas C. Shea

A method for the production of CD4+ chronic myelogenous leukemia- specific allogeneic T lymphocytes
Cancer Research. 1997;57(8):1547-1553.

9
69.
1996

N. Bandarenko; M.E. Brecher; H. Owen; J. Wiley; T. Shea; J. Serody

Thrombocytopenia in allogeneic peripheral blood stem cell collections.
Transfusion. 1996;36(7):668-669.

4
70.
1996

J.S. Serody; R.M. Poston; D. Weinstock; R.J. Kurlander; J.A. Frelinger

CD4⁺ cytolytic effecters are inefficient in the clearance of Listeria monocytogenes
Immunology. 1996;88(4):544-550.

5
71.
1995

J.H. Rex; J.E. Bennett; A.M. Sugar; P.G. Pappas; J. Serody; J.E. Edwards; R.G. Washburn

Intravascular catheter exchange and duration of candidemia
Clinical Infectious Diseases. 1995;21(4):994-996.

173
72.
1995

T. Shea; M. Graham; S. Bernard; A. Steagall; J. Wiley; J. Serody; M. Brecher; S. Bentley; C. Johnston; A. Vaisman; et al.

A clinical and pharmacokinetic study of high-dose carboplatin, paclitaxel, granulocyte colony-stimulating factor, and peripheral blood stem cells in patients with unresectable or metastatic cancer
Seminars in Oncology. 1995;22(5 SUPPL. 12):80-85.

21
73.
1994

B.E. Britigan; J.S. Serody; M.S. Cohen

The role of lactoferrin as an anti-inflammatory molecule
Advances in Experimental Medicine and Biology. 1994;357:143-156.

45
74.
1993

J.S. Serody; M.R. Mill; F.C. Detterbeck; D.T. Harris; M.S. Cohen

Blastomycosis in transplant recipients: Report of a case and review
Clinical Infectious Diseases. 1993;16(1):54-58.

36
75.
1992

M.S. Cohen; J. Mao; G.T. Rasmussen; J.S. Serody; B.E. Britigan

Interaction of lactoferrin and lipopolysaccharide (LPS): Effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced superoxide formation
Journal of Infectious Diseases. 1992;166(6):1375-1378.

55
76.
1991

B.E. Britigan; J.S. Serody; M.B. Hayek; L.M. Charniga; M.S. Cohen

Uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical and protects them from membrane autoperoxidation
Journal of Immunology. 1991;147(12):4271-4277.

34

Jonathan S Serody UNCCH, School of Medicine, Medicine

Jonathan S Serody

Jonathan S Serody
UNCCH, School of Medicine, Medicine